CCDC97 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.889700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.753400E-01
Normal-vs-Stage2
5.588100E-02
Normal-vs-Stage3
4.368500E-02
Normal-vs-Stage4
8.831000E-01
Stage1-vs-Stage2
5.537400E-01
Stage1-vs-Stage3
4.949600E-02
Stage1-vs-Stage4
2.658400E-01
Stage2-vs-Stage3
3.150100E-02
Stage2-vs-Stage4
5.246300E-02
Stage3-vs-Stage4
2.190200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.378500E-02
Normal-vs-AfricanAmerican
1.959580E-01
Normal-vs-Asian
1.832560E-01
Caucasian-vs-AfricanAmerican
6.919600E-01
Caucasian-vs-Asian
9.676600E-01
AfricanAmerican-vs-Asian
7.632000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.393800E-02
Normal-vs-Female
5.348500E-02
Male-vs-Female
5.843800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.098400E-01
Normal-vs-Age(41-60Yrs)
1.276630E-01
Normal-vs-Age(61-80Yrs)
6.412100E-02
Normal-vs-Age(81-100Yrs)
2.165600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.353200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.538000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.115610E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.723900E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.407800E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.736400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.411700E-02
Normal-vs-Daily Drinker
1.797400E-01
Normal-vs-Weekly Drinker
9.913600E-02
Normal-vs-Occasional Drinker
3.623200E-01
Normal-vs-Social Drinker
1.727710E-02
Non Drinker-vs-Daily Drinker
3.076300E-02
Non Drinker-vs-Weekly Drinker
4.000000E-01
Non Drinker-vs-Occasional Drinker
9.343800E-03
Non Drinker-vs-Social Drinker
4.049000E-01
Daily Drinker-vs-Weekly Drinker
3.219200E-01
Daily Drinker-vs-Occasional Drinker
5.075000E-01
Daily Drinker-vs-Social Drinker
1.867210E-01
Weekly Drinker-vs-Occasional Drinker
1.477200E-01
Weekly Drinker-vs-Social Drinker
8.974200E-01
Occasional Drinker-vs-Social Drinker
5.496400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.362400E-01
Normal-vs-Grade 2
6.165400E-01
Normal-vs-Grade 3
6.025000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.822600E-01
Grade 1-vs-Grade 3
9.561600E-01
Grade 1-vs-Grade 4
2.362400E-01
Grade 2-vs-Grade 3
7.303800E-01
Grade 2-vs-Grade 4
6.165400E-01
Grade 3-vs-Grade 4
6.025000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.872100E-02
Normal-vs-NonDiabetic
8.702200E-02
Diabetic-vs-NonDiabetic
1.456610E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.665700E-02
Normal-vs-NoPancreatitis
8.712000E-02
Pancreatitis-vs-NoPancreatitis
3.730800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.938000E-02
Normal-vs-N1
6.964500E-02
N0-vs-N1
8.723200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.588200E-01
Normal-vs-TP53-NonMutant
2.531200E-01
TP53-Mutant-vs-TP53-NonMutant
6.343000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
